Literature DB >> 25664061

Serum IL-17 and IL-6 increased accompany with TGF-β and IL-13 respectively in ulcerative colitis patients.

Jin-Shan Feng1, Zheng Yang2, Yu-Zhen Zhu3, Zhou Liu4, Can-Can Guo3, Xue-Bao Zheng1.   

Abstract

PURPOSES: To explorer the serum level of pro- and anti-inflammatory cytokines in the patients of ulcerative colitis and irritable bowel disease. And analyze the correlation between the cytokine's levels and disease's activity of ulcerative colitis patients.
METHODS: Serum cytokines of ulcerative colitis and irritable bowel syndrome with diarrhea patients including IL-6, IL-10, IL-13, IL-17, TNF-α and TGF-β were analyzed by enzyme linked immunosorbent assay, and ulcerative colitis activity were assessed by Mayo scoring system. The correlation of the serum level of cytokines and ulcerative colitis activity were analyzed by the SPSS 19.0 software.
RESULTS: Compared with healthy people, the serum level of IL-6, IL-10, IL-13, IL-17, TNF-α and TGF-β were elevated in ulcerative colitis patients. There is no direct correlation between each cytokines analyzed and the Mayo score. And the level of IL-6 is relevant to IL-13 (r=0.364, P=0.029), and the level of IL-17 is relevant to TGF-β (r=0.336, P=0.045).
CONCLUSION: When the pro-inflammatory cytokines increase in the serum of ulcerative colitis, the anti-inflammatory cytokines were increased concomitantly, Some cytokines are positive correlated, such as IL-6 and IL-13, IL-17 and TGF-β, the mechanism of which is complex and needs further investigation.

Entities:  

Keywords:  Ulcerative colitis; correlation; cytokine; irritable bowel syndrome; mayo score

Year:  2014        PMID: 25664061      PMCID: PMC4307508     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  26 in total

1.  Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease.

Authors:  B Vainer; O H Nielsen; J Hendel; T Horn; I Kirman
Journal:  Cytokine       Date:  2000-10       Impact factor: 3.861

2.  Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm.

Authors:  Marie-Christophe Boissier; Eric Assier; Géraldine Falgarone; Natacha Bessis
Journal:  Joint Bone Spine       Date:  2008-06-24       Impact factor: 4.929

Review 3.  Natural selection of tumor variants in the generation of "tumor escape" phenotypes.

Authors:  Hung T Khong; Nicholas P Restifo
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

4.  DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

Authors:  S Jahr; H Hentze; S Englisch; D Hardt; F O Fackelmayer; R D Hesch; R Knippers
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

5.  Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6.

Authors:  R Daig; G Rogler; E Aschenbrenner; D Vogl; W Falk; V Gross; J Schölmerich; T Andus
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

6.  Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission.

Authors:  C Van Kemseke; J Belaiche; E Louis
Journal:  Int J Colorectal Dis       Date:  2000-08       Impact factor: 2.571

7.  Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: correlation with disease activity.

Authors:  S Inoue; T Matsumoto; M Iida; M Mizuno; F Kuroki; K Hoshika; M Shimizu
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

8.  Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis.

Authors:  Rei Kawashima; Yuki I Kawamura; Tomoyuki Oshio; Aoi Son; Motomi Yamazaki; Teruki Hagiwara; Toshihiko Okada; Kyoko Inagaki-Ohara; Ping Wu; Suzanne Szak; Yutaka J Kawamura; Fumio Konishi; Oki Miyake; Hideaki Yano; Yukio Saito; Linda C Burkly; Taeko Dohi
Journal:  Gastroenterology       Date:  2011-09-03       Impact factor: 22.682

Review 9.  Irritable bowel syndrome: a little understood organic bowel disease?

Authors:  Nicholas J Talley; Robin Spiller
Journal:  Lancet       Date:  2002-08-17       Impact factor: 79.321

Review 10.  Interleukin 13 and its role in gut defence and inflammation.

Authors:  Peter Mannon; Walter Reinisch
Journal:  Gut       Date:  2012-09-01       Impact factor: 23.059

View more
  9 in total

1.  The Anti-Inflammatory Effect and Intestinal Barrier Protection of HU210 Differentially Depend on TLR4 Signaling in Dextran Sulfate Sodium-Induced Murine Colitis.

Authors:  Sisi Lin; Yongyu Li; Li Shen; Ruiqin Zhang; Lizhi Yang; Min Li; Kun Li; Jakub Fichna
Journal:  Dig Dis Sci       Date:  2016-12-19       Impact factor: 3.199

Review 2.  Mechanism and Management of Checkpoint Inhibitor-Related Toxicities in Genitourinary Cancers.

Authors:  Haoran Li; Kamal K Sahu; Benjamin L Maughan
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

3.  Gingko biloba extract (Ginaton) ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in mice via reducing IL-6/STAT3 and IL-23/IL-17.

Authors:  Yan Sun; Lian-Jie Lin; Yan Lin; Li-Xuan Sang; Min Jiang; Chang-Qing Zheng
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Clinical effects of ursodeoxycholic acid on patients with ulcerative colitis may improve via the regulation of IL-23-IL-17 axis and the changes of the proportion of intestinal microflora.

Authors:  Zhengjun Wang; Jinhua Chen; Zhiping Chen; Longke Xie; Wen Wang
Journal:  Saudi J Gastroenterol       Date:  2021 May-Jun       Impact factor: 2.485

5.  Immunological profiling of patients with ulcerative colitis leads to identification of two inflammatory conditions and CD1a as a disease marker.

Authors:  M Föhlinger; P Palamides; U Mansmann; F Beigel; M Siebeck; R Gropp
Journal:  J Transl Med       Date:  2016-11-03       Impact factor: 5.531

6.  Alterations in the mucosa-associated fungal microbiota in patients with ulcerative colitis.

Authors:  Xinyun Qiu; Jingjing Ma; Chunhua Jiao; Xiaqiong Mao; Xiaojing Zhao; Meijiao Lu; Kai Wang; Hongjie Zhang
Journal:  Oncotarget       Date:  2017-11-20

7.  INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS.

Authors:  Boris Takač; Silvio Mihaljević; Ljubica Glavaš-Obrovac; Aleksandar Kibel; Mirjana Suver-Stević; Silvija Canecki-Varžić; Marko Samardžija; Ines Rajkovac; Damir Kovač; Mario Štefanić
Journal:  Acta Clin Croat       Date:  2020-03       Impact factor: 0.780

8.  Crosstalk between Neospora caninum and the bovine host at the maternal-foetal interface determines the outcome of infection.

Authors:  Laura Jiménez-Pelayo; Marta García-Sánchez; Esther Collantes-Fernández; Javier Regidor-Cerrillo; Pilar Horcajo; Daniel Gutiérrez-Expósito; José Espinosa; Julio Benavides; Koldo Osoro; Christiane Pfarrer; Luis Miguel Ortega-Mora
Journal:  Vet Res       Date:  2020-06-17       Impact factor: 3.683

9.  Single Donor FMT Reverses Microbial/Immune Dysbiosis and Induces Clinical Remission in a Rat Model of Acute Colitis.

Authors:  Petra Adamkova; Petra Hradicka; Sona Gancarcikova; Monika Kassayova; Lubos Ambro; Izabela Bertkova; Martin Maronek; Silvia Farkasova Iannaccone; Vlasta Demeckova
Journal:  Pathogens       Date:  2021-02-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.